Metabolic and cognitive changes in hereditary ataxia

Elizabeth Matthew, Thomas E Nordahl, Lawrence Schut, Anna C. King, Robert Cohen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Fourteen subjects (affected, n = 7; at risk, n = 7) from one well-known kindred with adult onset autosomal dominant olivopontocerebellar atrophy (OPCA), were studied with [18F]-2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET), magnetic resonance imaging (MRI), cognitive testing and scored neurological examination, and compared with normal controls. The neurological examination, MRI and cognitive tests showed no significant differences between at risk and normal control subjects. Mild cognitive deficits were seen in affected subjects; the degree of cognitive change appeared to relate to the severity of the illness. MRI demonstrated cerebellar and brainstem atrophy in all affected subjects. PET studies showed higher global metabolic rates (mean [SD]) in at risk subjects (10.5 [1.5] mg per min per 100 g) as compared to affected (9.0 [0.8] mg per min per 100 g) and normal control subjects (9.1 [1.5] mg per min per 100 g). Normalized (region/global average) regional metabolic rates were reduced in cerebellar hemispheres and vermis, and in frontal and prefrontal areas of affected subjects in comparison to at risk and normal control subjects. These findings indicate that functional changes in some forms of autosomal dominant hereditary cerebellar ataxia may extend beyond the cerebellum and brainstem to involve other parts of the neuraxis.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalJournal of the Neurological Sciences
Volume119
Issue number2
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Spinocerebellar Degenerations
Magnetic Resonance Imaging
Neurologic Examination
Positron-Emission Tomography
Brain Stem
Olivopontocerebellar Atrophies
Cerebellar Ataxia
Cerebellum
Atrophy
Glucose

Keywords

  • Cerebellum
  • Cerebral glucose metabolism
  • Frontal cortex
  • Hereditary ataxia
  • Positron emission tomography
  • [F]-2-fluoro-2-deoxy-d-glucose

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Neuroscience(all)
  • Developmental Neuroscience
  • Neurology

Cite this

Metabolic and cognitive changes in hereditary ataxia. / Matthew, Elizabeth; Nordahl, Thomas E; Schut, Lawrence; King, Anna C.; Cohen, Robert.

In: Journal of the Neurological Sciences, Vol. 119, No. 2, 1993, p. 134-140.

Research output: Contribution to journalArticle

Matthew, Elizabeth ; Nordahl, Thomas E ; Schut, Lawrence ; King, Anna C. ; Cohen, Robert. / Metabolic and cognitive changes in hereditary ataxia. In: Journal of the Neurological Sciences. 1993 ; Vol. 119, No. 2. pp. 134-140.
@article{a774552ebe0744d081e835cf1a190db1,
title = "Metabolic and cognitive changes in hereditary ataxia",
abstract = "Fourteen subjects (affected, n = 7; at risk, n = 7) from one well-known kindred with adult onset autosomal dominant olivopontocerebellar atrophy (OPCA), were studied with [18F]-2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET), magnetic resonance imaging (MRI), cognitive testing and scored neurological examination, and compared with normal controls. The neurological examination, MRI and cognitive tests showed no significant differences between at risk and normal control subjects. Mild cognitive deficits were seen in affected subjects; the degree of cognitive change appeared to relate to the severity of the illness. MRI demonstrated cerebellar and brainstem atrophy in all affected subjects. PET studies showed higher global metabolic rates (mean [SD]) in at risk subjects (10.5 [1.5] mg per min per 100 g) as compared to affected (9.0 [0.8] mg per min per 100 g) and normal control subjects (9.1 [1.5] mg per min per 100 g). Normalized (region/global average) regional metabolic rates were reduced in cerebellar hemispheres and vermis, and in frontal and prefrontal areas of affected subjects in comparison to at risk and normal control subjects. These findings indicate that functional changes in some forms of autosomal dominant hereditary cerebellar ataxia may extend beyond the cerebellum and brainstem to involve other parts of the neuraxis.",
keywords = "Cerebellum, Cerebral glucose metabolism, Frontal cortex, Hereditary ataxia, Positron emission tomography, [F]-2-fluoro-2-deoxy-d-glucose",
author = "Elizabeth Matthew and Nordahl, {Thomas E} and Lawrence Schut and King, {Anna C.} and Robert Cohen",
year = "1993",
doi = "10.1016/0022-510X(93)90125-I",
language = "English (US)",
volume = "119",
pages = "134--140",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Metabolic and cognitive changes in hereditary ataxia

AU - Matthew, Elizabeth

AU - Nordahl, Thomas E

AU - Schut, Lawrence

AU - King, Anna C.

AU - Cohen, Robert

PY - 1993

Y1 - 1993

N2 - Fourteen subjects (affected, n = 7; at risk, n = 7) from one well-known kindred with adult onset autosomal dominant olivopontocerebellar atrophy (OPCA), were studied with [18F]-2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET), magnetic resonance imaging (MRI), cognitive testing and scored neurological examination, and compared with normal controls. The neurological examination, MRI and cognitive tests showed no significant differences between at risk and normal control subjects. Mild cognitive deficits were seen in affected subjects; the degree of cognitive change appeared to relate to the severity of the illness. MRI demonstrated cerebellar and brainstem atrophy in all affected subjects. PET studies showed higher global metabolic rates (mean [SD]) in at risk subjects (10.5 [1.5] mg per min per 100 g) as compared to affected (9.0 [0.8] mg per min per 100 g) and normal control subjects (9.1 [1.5] mg per min per 100 g). Normalized (region/global average) regional metabolic rates were reduced in cerebellar hemispheres and vermis, and in frontal and prefrontal areas of affected subjects in comparison to at risk and normal control subjects. These findings indicate that functional changes in some forms of autosomal dominant hereditary cerebellar ataxia may extend beyond the cerebellum and brainstem to involve other parts of the neuraxis.

AB - Fourteen subjects (affected, n = 7; at risk, n = 7) from one well-known kindred with adult onset autosomal dominant olivopontocerebellar atrophy (OPCA), were studied with [18F]-2-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET), magnetic resonance imaging (MRI), cognitive testing and scored neurological examination, and compared with normal controls. The neurological examination, MRI and cognitive tests showed no significant differences between at risk and normal control subjects. Mild cognitive deficits were seen in affected subjects; the degree of cognitive change appeared to relate to the severity of the illness. MRI demonstrated cerebellar and brainstem atrophy in all affected subjects. PET studies showed higher global metabolic rates (mean [SD]) in at risk subjects (10.5 [1.5] mg per min per 100 g) as compared to affected (9.0 [0.8] mg per min per 100 g) and normal control subjects (9.1 [1.5] mg per min per 100 g). Normalized (region/global average) regional metabolic rates were reduced in cerebellar hemispheres and vermis, and in frontal and prefrontal areas of affected subjects in comparison to at risk and normal control subjects. These findings indicate that functional changes in some forms of autosomal dominant hereditary cerebellar ataxia may extend beyond the cerebellum and brainstem to involve other parts of the neuraxis.

KW - Cerebellum

KW - Cerebral glucose metabolism

KW - Frontal cortex

KW - Hereditary ataxia

KW - Positron emission tomography

KW - [F]-2-fluoro-2-deoxy-d-glucose

UR - http://www.scopus.com/inward/record.url?scp=0027371289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027371289&partnerID=8YFLogxK

U2 - 10.1016/0022-510X(93)90125-I

DO - 10.1016/0022-510X(93)90125-I

M3 - Article

C2 - 8277326

AN - SCOPUS:0027371289

VL - 119

SP - 134

EP - 140

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -